Violation Tracker Individual Record

Company: 
Novartis Pharmaceuticals
Current Parent Company: 
Novartis
Penalty: 
$6,638,250
Year: 
2012
Date: 
October 30, 2012
Offense Group: 
healthcare-related offenses
Primary Offense: 
off-label or unapproved promotion of medical products
Violation Description: 

The settlement resolved allegations of unlawfully marketing the eczema drug Elidel to treat infant children while failing to disclose the drug's known harmful side effects.

Level of Government: 
state
Action Type: 
agency action
Agency: 
Texas Attorney General
Civil or Criminal Case: 
civil
Facility State: 
Texas
HQ Country of Parent: 
Switzerland
Ownership Structure of Parent: 
publicly traded
Major Industry of Parent: 
pharmaceuticals
Specific Industry of Parent: 
pharmaceuticals
Source of Data: 

Texas Attorney General's Office Secures $19.9 Million Agreement with Drug Maker Over Medicaid Fraud Allegations, Targeted News Service, October 30, 2012 (via Nexis).

Source Notes: 
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note: 
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.